Acceso abierto

Diagnosis of human cytomegvirus association with malignant gliomas and pro- and anti-inflammatories


Cite

1. Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev. 2009;22:76-98.10.1128/CMR.00034-08Search in Google Scholar

2. Hummel M, Abecassis MM. A model for reactivation of CMV from latency. J Clin Virol. 2002;25:123-36.10.1016/S1386-6532(02)00088-4Search in Google Scholar

3. MC Guedes MI, Risdahl JM, Wiseman B, Molitor TW. Reactivation of porcine cytomegalovirus through allogeneic stimulation. J Clin Microbiol. 2004;42:1756-8.10.1128/JCM.42.4.1756-1758.2004Search in Google Scholar

4. Muller LV, Klemn A, Weiss M, Schneider M, Sugar-Wiedeck H, Durmus N, et al. Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis. 2006;12:1517-22.10.3201/eid1210.060411Search in Google Scholar

5. Taher C, de Boniface J, Mohammad AA, Religa P, Hartman J, Yaiw KC, et al. High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes. PLos One. 2013;10:1371-7.10.1371/journal.pone.0056795Search in Google Scholar

6. Kaveh B. Oncomodulatory mechanism of HCMV in glioma. J Clin Neurosci. 2010;17:819-23.10.1016/j.jocn.2009.10.040Search in Google Scholar

7. Samanta M, Harkins L, Cobbs CS, Yancey Gillespie G, Bharara S, King PH, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002;62(12):3347-50.Search in Google Scholar

8. Joki T, Kikuchi T, Akasaki Y, Saitoh S, Abe T, Ohno T. Induction of effective antitumor immunity in a mouse brain tumor model using B7-1(CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12. Int J Cancer. 1999;82:714.10.1002/(SICI)1097-0215(19990827)82:5<714::AID-IJC15>3.0.CO;2-QSearch in Google Scholar

9. Michelucci A, Heurtaux T, Grandbarbe L, Morga E, Heuschling P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol. 2009;210:3-12.10.1016/j.jneuroim.2009.02.003Search in Google Scholar

10. Howard M, Farrar J, Hilfiker M, Johnson B, Takatsu K, Hamaoka T, Paul WE. Identification of a T cell-derived b cell growth factor distinct from interleukin 2. J Exp Med. 1982;155:914-2310.1084/jem.155.3.914Search in Google Scholar

11. Antoine GC, Jean CN, Chahrazed B, Axelle D, Yanne M, Elyanne G. Quantification of Human Cytomegalovirus DNA by Real-Time PCR. J Clin Microbiol. 2001;39(2) 772-5.10.1128/JCM.39.2.772-775.2001Search in Google Scholar

12. Iraqi Cancer Registry; 2005Search in Google Scholar

13. Brousset P, Delisle MB, Trémoulet M, Allart S, Labrousse F, Pommepuy I, Uro-Coste E. Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Brit J Cancer. 2005;92:747-50.10.1038/sj.bjc.6602339236188215700045Search in Google Scholar

14. El-Zein R, Albrecht T, Aldape KD, Bondy ML, Scheurer ME. Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol. 2008;116(1):79-86.10.1007/s00401-008-0359-1300127718351367Search in Google Scholar

15. Udai PS, Haider SK, Aws RH, Abdulameer K, Dennis DT, Robert LP, et al. Detection of human cytomegalovirus in different histo-pathological types of glioma in Iraqi patients. Hindawi Publishing Corporation. BioMed Res Int. 2015;10.10.1155/2015/642652433140325710012Search in Google Scholar

16. Sampson JH, Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro-Oncology. 2008;10(1):10-8.10.1215/15228517-2007-035260083017951512Search in Google Scholar

17. Puri KR, Varricchio F, Prayson AR, Joshi BH, Leland P, Asher A. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures. Cancer Res. 2001;61:8058-61.Search in Google Scholar

18. Kranz MD, Webb AG. IL-12 Treatment of Endogenously Arising. J Immunol. 2016;165:7293-9.Search in Google Scholar

19. Kipnis J, Norris T, Cronk CJ, Gadani SP. IL-4 in the brain. J Immunol. 2016;189:4213-9.Search in Google Scholar

20. Puri KR, Varricchio F, Prayson AR, Joshi BH, Leland P, Asher A. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures. Cancer Res. 2001;61:8058-61.Search in Google Scholar

21. Kranz MD, Webb AG. IL-12 Treatment of endogenously arising. J Immunol. 2016;165:7293-9.Search in Google Scholar

22. Kipnis J, Norris T, Cronk CJ, Gadani SP. IL-4 in the brain. J Immunol. 2016;189:4213-9.Search in Google Scholar

eISSN:
2300-6676
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicine, Clinical Medicine, other, Pharmacology, Toxicology, Pharmacy